Is equol the key to the efficacy of soy foods?
- 1 May 2009
- journal article
- Published by Elsevier BV in The American Journal of Clinical Nutrition
- Vol. 89 (5), 1664S-1667S
- https://doi.org/10.3945/ajcn.2009.26736t
Abstract
Gut bacterial modification of soy isoflavones produces metabolites that differ in biological activity from the parent compounds. Hydrolysis of glycosides results in more active compounds. In contrast, further degradation and transformation of aglycones produce more or less active compounds, depending on the substrate metabolized and the product formed. Bacterial metabolism of soy isoflavones varies among individuals. The predominant daidzein metabolites produced by human intestinal bacteria are equol and O-desmethylangolensin. Among humans, 30–50% have the bacteria capable of producing equol and 80–90% harbor O-desmethylangolensin–producing bacteria. Factors that influence the capacity to produce equol and O-desmethylangolensin are not clearly established; however, gut physiology, host genetics, and diet are reported to contribute to interindividual differences in conversion of daidzein to equol. Effects of these phenotypes on human health are poorly characterized. Some studies in high soy–consuming populations reported an inverse association between urinary and serum equol concentrations and breast and prostate cancer risk. Furthermore, several studies of soy supplementation and bone density suggest that soy products may be more effective in maintaining bone density in equol-producing individuals. Factors that contribute to the phenotypes and the relation of these specific phenotypes to human health need to be further elucidated. The extent to which isoflavone metabolism is key to the efficacy of soy foods remains to be established.Keywords
This publication has 58 references indexed in Scilit:
- Serum 25-hydroxyvitamin D status of vegetarians, partial vegetarians, and nonvegetarians: the Adventist Health Study-2The American Journal of Clinical Nutrition, 2009
- Nuts and health outcomes: new epidemiologic evidenceThe American Journal of Clinical Nutrition, 2009
- Mortality in British vegetarians: results from the European Prospective Investigation into Cancer and Nutrition (EPIC-Oxford)The American Journal of Clinical Nutrition, 2009
- Vegetarian diets: what do we know of their effects on common chronic diseases?The American Journal of Clinical Nutrition, 2009
- A low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: a randomized, controlled, 74-wk clinical trialThe American Journal of Clinical Nutrition, 2009
- Dietary change and reduced breast cancer events among women without hot flashes after treatment of early-stage breast cancer: subgroup analysis of the Women’s Healthy Eating and Living StudyThe American Journal of Clinical Nutrition, 2009
- Interindividual differences in response to plant-based diets: implications for cancer riskThe American Journal of Clinical Nutrition, 2009
- Food synergy: an operational concept for understanding nutritionThe American Journal of Clinical Nutrition, 2009
- Interindividual differences in phytochemical metabolism and dispositionSeminars in Cancer Biology, 2007
- Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do notThe Journal of Nutritional Biochemistry, 2007